{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:00:23Z","timestamp":1790816423334,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"vor","delay-in-days":395,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jacc.2016.02.081","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T14:10:50Z","timestamp":1464099050000},"page":"2533-2546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":364,"title":["Dystrophin-Deficient Cardiomyopathy"],"prefix":"10.1016","volume":"67","author":[{"given":"Forum","family":"Kamdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2016.02.081_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/095952875203500108","article-title":"On granular and fatty degeneration of the voluntary muscles","volume":"35","author":"Meryon","year":"1852","journal-title":"Medico-Chirugical Trans"},{"key":"10.1016\/j.jacc.2016.02.081_bib2","first-page":"5","article-title":"Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myo-sclerosique","volume":"11","author":"Duchenne","year":"1868","journal-title":"Arch Gen Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib3","series-title":"A\u00a0manual of disease of the nervous system","first-page":"391","volume":"1","author":"Gowers","year":"1886"},{"key":"10.1016\/j.jacc.2016.02.081_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/323646a0","article-title":"Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene","volume":"323","author":"Monaco","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2016.02.081_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2016.02.081_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.02.081_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00001573-199705000-00015","article-title":"Dystrophies and heart disease","volume":"12","author":"Cox","year":"1997","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jacc.2016.02.081_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2016.02.081_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ng0493-283","article-title":"The structural and functional diversity of dystrophin","volume":"3","author":"Ahn","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2016.02.081_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajmg.a.30617","article-title":"Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort","volume":"134","author":"Dent","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jacc.2016.02.081_bib12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1083\/jcb.150.5.1209","article-title":"The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin","volume":"150","author":"Rybakova","year":"2000","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jacc.2016.02.081_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A\u00a0role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jacc.2016.02.081_bib14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T","article-title":"Molecular basis of muscular dystrophies","volume":"23","author":"Cohn","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jacc.2016.02.081_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.RES.72.2.349","article-title":"Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle","volume":"72","author":"Klietsch","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.02.081_bib16","doi-asserted-by":"crossref","first-page":"e43515","DOI":"10.1371\/journal.pone.0043515","article-title":"Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins","volume":"7","author":"Johnson","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jacc.2016.02.081_bib17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/364725a0","article-title":"Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity","volume":"364","author":"Cox","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2016.02.081_bib18","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2016.02.081_bib19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nature03844","article-title":"Dystrophic heart failure blocked by membrane sealant poloxamer","volume":"436","author":"Yasuda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2016.02.081_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2169\/internalmedicine1962.25.2","article-title":"Regularity in the change of serum creatine kinase level in Duchenne muscular dystrophy. A study with long-term follow-up cases","volume":"25","author":"Konagaya","year":"1986","journal-title":"Jpn J Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jacc.2016.02.081_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mus.20812","article-title":"The role of corticosteroids in muscular dystrophy: a critical appraisal","volume":"36","author":"Angelini","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jacc.2016.02.081_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2016.02.081_bib25","first-page":"CD003725","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2016.02.081_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F","article-title":"A\u00a0multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy","volume":"23","author":"Bonifati","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jacc.2016.02.081_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2016.02.081_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1099-0496(200002)29:2<141::AID-PPUL9>3.0.CO;2-Y","article-title":"Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy","volume":"29","author":"Gozal","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jacc.2016.02.081_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.nmd.2007.03.002","article-title":"Managing Duchenne muscular dystrophy\u2014the additive effect of spinal surgery and home nocturnal ventilation in improving survival","volume":"17","author":"Eagle","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jacc.2016.02.081_bib30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.200307-885ST","article-title":"Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement","volume":"170","author":"Finder","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1542\/peds.2005-2448","article-title":"Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy","volume":"116","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacc.2016.02.081_bib32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00246-005-0909-4","article-title":"Steroid therapy and cardiac function in Duchenne muscular dystrophy","volume":"26","author":"Markham","year":"2005","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib33","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.104.528281","article-title":"Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy","volume":"112","author":"Jefferies","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.02.081_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11897-010-0028-2","article-title":"Cardiac assessment in Duchenne and Becker muscular dystrophies","volume":"7","author":"Romfh","year":"2010","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacc.2016.02.081_bib35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.amjcard.2008.08.064","article-title":"Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy","volume":"103","author":"Thrush","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0002-9343(67)90017-4","article-title":"The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study","volume":"42","author":"Perloff","year":"1967","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.57.6.1122","article-title":"An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy","volume":"57","author":"Sanyal","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.02.081_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0046-8177(76)80053-6","article-title":"The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis","volume":"7","author":"Frankel","year":"1976","journal-title":"Human Pathol"},{"key":"10.1016\/j.jacc.2016.02.081_bib39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.echo.2006.02.003","article-title":"Abnormalities of diastolic function precede dilated cardiomyopathy associated with Duchenne muscular dystrophy","volume":"19","author":"Markham","year":"2006","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2016.02.081_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/archinte.1931.00140210039003","article-title":"The heart rate in progressive muscular dystrophy","volume":"47","author":"Boas","year":"1931","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib41","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.35.6.1124","article-title":"The Frank vectorcardiogram and the electrocardiogram in Duchenne progressive muscular dystrophy","volume":"35","author":"Fitch","year":"1967","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.02.081_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.CIR.52.3.447","article-title":"Echocardiographic evaluation of posterior left ventricular wall motion in muscular dystrophy","volume":"52","author":"Kovick","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.02.081_bib43","first-page":"1027","article-title":"Histopathological study of the conduction system of the heart in Duchenne progressive muscular dystrophy","volume":"32","author":"Nomura","year":"1982","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.jacc.2016.02.081_bib44","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9149(99)80267-7","article-title":"Circadian rhythm and variability of heart rate in Duchenne-type progressive muscular dystrophy","volume":"76","author":"Yotsukura","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/hj.1998.v136.89737","article-title":"Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy","volume":"136","author":"Yotsukura","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2016.02.081_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00246-012-0281-0","article-title":"Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy","volume":"33","author":"Thomas","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01243426","article-title":"The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution","volume":"46","author":"Dalmaz","year":"1979","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.jacc.2016.02.081_bib48","doi-asserted-by":"crossref","first-page":"e002620","DOI":"10.1161\/JAHA.115.002620","article-title":"Ambulatory monitoring and arrhythmic outcomes in pediatric and adolescent patients with Duchenne muscular dystrophy","volume":"5","author":"Villa","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2016.02.081_bib49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0002-9149(02)02195-1","article-title":"Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy","volume":"89","author":"Corrado","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0002-8703(99)70221-8","article-title":"QT dispersion in patients with Duchenne-type progressive muscular dystrophy","volume":"137","author":"Yotsukura","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2016.02.081_bib51","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/hrt.2006.087643","article-title":"Echocardiographic clues to diagnosis of dystrophin related dilated cardiomyopathy","volume":"93","author":"Rapezzi","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2016.02.081_bib53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","article-title":"Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy","volume":"18","author":"Markham","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jacc.2016.02.081_bib54","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jacc.2006.10.078","article-title":"Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy","volume":"49","author":"Silva","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib55","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.amjcard.2009.12.070","article-title":"Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy","volume":"105","author":"Hagenbuch","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib56","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jacc.2008.12.032","article-title":"Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study","volume":"53","author":"Hor","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10554-008-9352-y","article-title":"Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?","volume":"25","author":"Puchalski","year":"2009","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2016.02.081_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCIMAGING.110.960740","article-title":"Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations","volume":"4","author":"Verhaert","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2016.02.081_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1532-429X-15-107","article-title":"Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function","volume":"15","author":"Hor","year":"2013","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2016.02.081_bib60","doi-asserted-by":"crossref","first-page":"e001338","DOI":"10.1161\/JAHA.114.001338","article-title":"Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy","volume":"4","author":"Tandon","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2016.02.081_bib61","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jacc.2012.12.011","article-title":"Steroid therapy effectively delays Duchenne's cardiomyopathy","volume":"61","author":"Dec","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib62","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0002-9149(02)03429-X","article-title":"Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy","volume":"91","author":"Silversides","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpn.2008.02.006","article-title":"Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study","volume":"13","author":"Mavrogeni","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jacc.2016.02.081_bib64","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jpeds.2013.05.060","article-title":"Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy","volume":"163","author":"Barber","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jacc.2016.02.081_bib65","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","article-title":"All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy","volume":"61","author":"Schram","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib66","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib67","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","article-title":"Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up","volume":"154","author":"Duboc","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2016.02.081_bib68","article-title":"A\u00a0randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"5","author":"Allen","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.jacc.2016.02.081_bib69","first-page":"691","article-title":"[Carvedilol effectiveness for left ventricular-insufficient patients with Duchenne muscular dystrophy]","volume":"41","author":"Saito","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jacc.2016.02.081_bib70","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00246-007-9113-z","article-title":"Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy","volume":"29","author":"Rhodes","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib71","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1253\/circj.70.991","article-title":"Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy","volume":"70","author":"Kajimoto","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2016.02.081_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2012.02.064","article-title":"Effects of angiotensin-converting enzyme inhibitors and\/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy","volume":"110","author":"Viollet","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2016.02.081_bib74","first-page":"804","article-title":"Heart\u00a0transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy","volume":"12","author":"Rees","year":"1993","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2016.02.081_bib75","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0041-1345(03)00515-3","article-title":"Successful heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy","volume":"35","author":"Ruiz-Cano","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jacc.2016.02.081_bib76","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejcts.2005.11.012","article-title":"Successful heart transplantation in Becker's muscular dystrophy","volume":"29","author":"Patan\u00e8","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2016.02.081_bib77","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.healun.2009.08.030","article-title":"Clinical outcomes after cardiac transplantation in muscular dystrophy patients","volume":"29","author":"Wu","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2016.02.081_bib78","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib79","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib80","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ijcard.2012.04.009","article-title":"Left ventricular assist device in Duchenne cardiomyopathy: can we change the natural history of cardiac disease?","volume":"161","author":"Amodeo","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MAT.0000000000000050","article-title":"Implantation of the HeartMate II and HeartWare left ventricular assist devices in patients with Duchenne muscular dystrophy: lessons learned from the first applications","volume":"60","author":"Ryan","year":"2014","journal-title":"ASAIO J"},{"key":"10.1016\/j.jacc.2016.02.081_bib82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00343141","article-title":"[A new x-chromosomal muscular dystrophy]","volume":"193","author":"Becker","year":"1955","journal-title":"Archiv Psychiatr Nervenkr Z Gesamte Neurol Psychiatr"},{"key":"10.1016\/j.jacc.2016.02.081_bib83","first-page":"551","article-title":"Two families of benign sex-linked recessive muscular dystrophy","volume":"21","author":"Becker","year":"1962","journal-title":"Rev Can Biol"},{"key":"10.1016\/j.jacc.2016.02.081_bib84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00270551","article-title":"Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences","volume":"67","author":"Kingston","year":"1984","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacc.2016.02.081_bib85","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2016.02.081_bib86","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1126\/science.270.5237.755","article-title":"Muscular dystrophies: diseases of the dystrophin-glycoprotein complex","volume":"270","author":"Worton","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.02.081_bib87","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.jacc.2016.02.081_bib88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.880010204","article-title":"Becker-type muscular dystrophy","volume":"1","author":"Bradley","year":"1978","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jacc.2016.02.081_bib89","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/01.CIR.94.12.3168","article-title":"Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy","volume":"94","author":"Melacini","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.02.081_bib90","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0828-282X(08)70686-X","article-title":"Cardiac involvement in Becker muscular dystrophy","volume":"24","author":"Finsterer","year":"2008","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib91","first-page":"657","article-title":"Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period","volume":"244","author":"Hoogerwaard","year":"1997","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jacc.2016.02.081_bib92","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0960-8966(94)90073-6","article-title":"Mutation of dystrophin gene and cardiomyopathy","volume":"4","author":"Nigro","year":"1994","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.jacc.2016.02.081_bib93","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1532-429X-10-50","article-title":"Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach","volume":"10","author":"Yilmaz","year":"2008","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2016.02.081_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-0004.1989.tb03363.x","article-title":"A\u00a0survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales","volume":"36","author":"Norman","year":"1989","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacc.2016.02.081_bib95","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0167-5273(92)90028-2","article-title":"The cardiomyopathy of Duchenne\/Becker consultands","volume":"34","author":"Comi","year":"1992","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib96","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0960-8966(99)00018-8","article-title":"Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy","volume":"9","author":"Hoogerwaard","year":"1999","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.jacc.2016.02.081_bib97","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(98)10028-4","article-title":"Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study","volume":"353","author":"Hoogerwaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.02.081_bib98","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.0b013e318221ad14","article-title":"Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy","volume":"77","author":"Schade van Westrum","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2016.02.081_bib99","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1007\/s00330-015-3694-3","article-title":"Cardiac pathologies in female carriers of Duchenne muscular dystrophy assessed by cardiovascular magnetic resonance imaging","volume":"25","author":"Schelhorn","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00246-015-1192-7","article-title":"Myocardial fibrosis and left ventricular dysfunction in Duchenne muscular dystrophy carriers using cardiac magnetic resonance imaging","volume":"36","author":"Lang","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2016.02.081_bib101","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM198705073161904","article-title":"X-linked dilated cardiomyopathy","volume":"316","author":"Berko","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib102","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM199309233291304","article-title":"Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy","volume":"329","author":"Muntoni","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib103","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","article-title":"X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus","volume":"87","author":"Towbin","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.02.081_bib104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacc.2016.02.081_bib105","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne's muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib106","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.02.081_bib107","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/mt.2011.59","article-title":"Current status of pharmaceutical and genetic therapeutic approaches to treat DMD","volume":"19","author":"Pichavant","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacc.2016.02.081_bib108","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin","volume":"343","author":"England","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2016.02.081_bib109","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nm1439","article-title":"rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice","volume":"12","author":"Gregorevic","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib111","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mcn.2008.12.011","article-title":"Truncated dystrophins can influence neuromuscular synapse structure","volume":"40","author":"Banks","year":"2009","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jacc.2016.02.081_bib112","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne's muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.02.081_bib113","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/mt.2011.237","article-title":"Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector","volume":"20","author":"Bowles","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacc.2016.02.081_bib114","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A\u00a0programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.02.081_bib115","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.02.081_bib116","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.02.081_bib117","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.02.081_bib118","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In\u00a0vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716326080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716326080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T20:50:06Z","timestamp":1536699006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109716326080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":118,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0735109716326080"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2016.02.081","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dystrophin-Deficient Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.02.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}